Global Losartan Potassium Market 2023-2030

    In Stock

    Coming Soon




    Angiotensin II receptor blockers are a class of medications that includes losartan potassium. (ARBs). It helps to prevent kidney damage brought on by diabetes and is used to treat high blood pressure (hypertension).


    Angiotensin II, a hormone that tightens blood vessels and elevates blood pressure, is blocked by losartan in order to work. Losartan aids in dilating blood vessels and lowering blood pressure by preventing the action of angiotensin II. 


    With or without food, losartan potassium is typically taken orally once per day. Depending on the patient’s medical condition and reaction to treatment, the medication’s dosage and frequency may change.


    Losartan potassium side effects can include headache, fatigue, diarrhea, and dizziness, just as with other medicine.


    More severe side effects include low blood pressure, allergic reactions, and liver issues can occasionally result from it. Before using losartan potassium, it’s crucial to talk to your doctor, especially if you have a history of liver or kidney issues, are pregnant, or are nursing a baby.




    infographic: Losartan Potassium Market, Losartan Potassium Market Size, Losartan Potassium Market Trends, Losartan Potassium Market Forecast, Losartan Potassium Market Risks, Losartan Potassium Market Report, Losartan Potassium Market Share


    Global losartan potassium market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    Losartan potassium has being investigated as a potential COVID-19 therapy. In hospitalised patients with COVID-19 and acute lung injury, a randomised clinical trial involving 205 patients indicated that maximal dose losartan did not reduce lung injury at 7 days.


    By decreasing the function of epithelial sodium channels (ENaC), SARS-CoV-2 may disrupt potassium balance, according to another study Losartan was tested in a clinical trial to see if it worked for COVID-19 patients who needed to be hospitalised.


    Losartan may lessen the activity of the renin-angiotensin system, which is overactive in persons with high blood pressure and may raise their chance of having lung issues from COVID-19. Losartan does not stop the virus that causes COVID-19.


    The clinical symptoms of COVID-19 have frequently been described as electrolyte problems, particularly potassium abnormalities.


    However, there is no proof that losartan has any impact on COVID-19 patients’ potassium levels. Losartan’s effectiveness for COVID-19 patients who needed to be hospitalised was examined in a clinical trial The purpose of the research was to see if losartan may lessen the requirement for hospitalization, supplemental oxygen use, or mechanical breathing in COVID-19 patients. The experiment ended on February.





    1. How many losartan potassium are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global losartan potassium and key vendor selection criteria
    3. Where is the losartan potassium manufactured? What is the average margin per unit?
    4. Market share of Global losartan potassium market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global losartan potassium in-house
    6. key predictions for next 5 years in Global losartan potassium market
    7. Average B-2-B losartan potassium market price in all segments
    8. Latest trends in losartan potassium market, by every market segment
    9. The market size (both volume and value) of the losartan potassium market in 2023-2030 and every year in between?
    10. Production breakup of losartan potassium market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop